MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 13.11.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
2018 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ CAPITALSPB |
Anteile |
1.27 M |
Marktkapitalisierung |
$ 2.03 M |
EBITDA (LTM) |
$ -94.1 M |
P/E (LTM) |
-0.04 |
P/S (LTM) |
0.08 |
EPS (LTM) |
-35.65 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Brainsway Ltd.
BWAY
|
$ 23.11 | 4.52 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 23.0 | 2.86 % | $ 248 M | Nasdaq Global Market |  China |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Co-Diagnostics
CODX
|
$ 6.1 | 1.16 % | $ 179 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 39.93 | -1.67 % | $ 1.11 B | Nasdaq Global Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 234.99 | -0.25 % | $ 172 B | NYSE,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DarioHealth Corp.
DRIO
|
$ 12.98 | 6.97 % | $ 368 M | Nasdaq Capital Market | Israel |
 |
DexCom
DXCM
|
$ 68.47 | -2.33 % | $ 26.4 B | Nasdaq Global Select Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 17.5 | -7.41 % | $ 941 M | Nasdaq Global Market,SPB | USA |
 |
Celcuity
CELC
|
$ 105.54 | -3.33 % | $ 4.16 B | Nasdaq Global Select Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.4 | 3.66 % | $ 108 K | Nasdaq Capital Market | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 101.77 | 0.14 % | $ 18.9 B | Nasdaq Capital Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 27.9 | -0.39 % | $ 844 M | Nasdaq Global Market | USA |
 |
Guardant Health
GH
|
$ 107.75 | -1.98 % | $ 13.2 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
$ 48.19 | 1.71 % | $ 10.7 B | NYSE |  Niderland |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Illumina
ILMN
|
$ 146.41 | -2.48 % | $ 23.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 214.0 | -1.51 % | $ 11 B | NYSE,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 243.4 | -0.36 % | $ 44.1 B | NYSE,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 177.06 | -0.64 % | $ 19.7 B | NYSE,SPB | USA |
|
Biodesix
BDSX
|
$ 5.77 | -3.27 % | $ 748 M | Nasdaq Global Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 254.76 | 0.43 % | $ 21.4 B | NYSE,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 189.39 | -6.67 % | $ 15.6 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 708.9 | -0.79 % | $ 58.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 68.27 | -1.59 % | $ 4.72 B | Nasdaq Global Select Market,SPB | USA |
 |
Agilent Technologies
A
|
$ 145.56 | -1.51 % | $ 44.3 B | NYSE,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.83 | 1.8 % | $ 6.5 M | Nasdaq Capital Market | USA |
 |
Bioventus
BVS
|
$ 8.0 | 5.12 % | $ 501 M | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 29.47 | 1.25 % | $ 20 B | NYSE | Niderland |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Precipio
PRPO
|
$ 23.85 | 2.49 % | $ 31 M | Nasdaq Global Select Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 461.94 | -0.56 % | $ 31 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 6.63 | -0.08 % | $ 601 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.64 | 1.75 % | $ 2.49 M | Nasdaq Global Select Market | USA |